| Identifier |
20230315_nanos_surgery1_06 |
| Title |
Should I Have Teprotumumab or Surgery? |
| Creator |
Alison V. Crum |
| Affiliation |
John A. Moran Eye Center, University of Utah, Salt Lake City, UT |
| Subject |
Thyroid Orbitopathy; Thyroid Eye Disease; Teprotumumab; Proptosis; Diplopia |
| Description |
Pathophysiology of thyroid eye disease/thyroid orbitopathy and teprotumumab: In orbitopathy, it is believed that there is a cross reaction of thyroid auto-antibodies with the thyrotropin receptor (TSHR) and the insulin growth factor receptor (IGFR) on orbital fibroblasts. |
| Date |
2023-03 |
| Language |
eng |
| Format |
application/pdf |
| Type |
Text |
| Source |
2023 North American Neuro-Ophthalmology Society Annual Meeting |
| Relation is Part of |
NANOS Annual Meeting 2023: Ophthalmic Surgery in the Neuro-Ophthalmic Patient |
| Collection |
Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/ |
| Publisher |
North American Neuro-Ophthalmology Society |
| Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
| Rights Management |
Copyright 2023. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
| ARK |
ark:/87278/s6sxhzqn |
| Setname |
ehsl_novel_nam |
| ID |
2309975 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6sxhzqn |
